Tocilizumab given through fluid-draining tubes for advanced cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a drug called tocilizumab, which is given through the tube that drains fluid from your chest or belly. The goal is to see if it can help control cancer-related fluid buildup and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 89 years old.
- Your cancer has spread and caused fluid buildup in your chest or belly (doctor has confirmed this).
- You are already scheduled to get a tube (catheter) placed to drain this fluid.
- You are able to take care of most daily activities (ECOG score 0-2).
- You do not have a serious infection, autoimmune disease, or known allergy to the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new therapy using your own immune cells (called TILs) to treat cancer that has spread to the lining of the lungs. The goal is to see if these cells can shrink tumors and help you feel better.
This trial tests a treatment using your own immune cells (T cells) to fight cancer that has spread to the lining of the lung and is causing fluid buildup. It may help if other standard treatments have stopped working.
This study tests an experimental drug called WSK-IM02 that is given directly into the chest or belly to treat fluid buildup caused by advanced cancer. It may help reduce symptoms like shortness of breath or belly swelling and improve quality of life.
This trial tests three drugs (bevacizumab, serplulimab, and rmhTNF-NC) given together to treat fluid buildup in the belly caused by digestive system cancers. It’s for people whose ascites has not improved after standard treatments.
This trial studies whether an immune-blocking drug placed directly into the belly cavity can help people with cancer-caused fluid buildup (malignant ascites) from stomach, pancreas, or bile-duct cancers. It may help shrink the fluid and slow the illness, but you must meet specific safety and treatment-history requirements.
This trial tests whether adding tocilizumab, a drug that calms the immune system, to standard chemotherapy helps control certain advanced breast cancers. It is for people with triple-negative or ER-positive, HER2-negative breast cancer that has spread or come back.
Hear when a new Malignant Pleural Effusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.